Alan Carr
Stock Analyst
(n/a)
# 4,492
Out of 4,497 analysts
13
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Downgrades: Hold | n/a | $121.14 | - | 3 | Dec 9, 2020 | |
| VIR Vir Biotechnology | Initiates: Buy | n/a | $10.03 | - | 1 | Aug 20, 2020 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | n/a | $54.56 | - | 1 | Jul 28, 2020 | |
| PCVX Vaxcyte | Initiates: Buy | n/a | $81.63 | - | 1 | Jul 7, 2020 | |
| PLRX Pliant Therapeutics | Initiates: Buy | n/a | $12.36 | - | 1 | Jun 29, 2020 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | n/a | $237.83 | - | 2 | May 6, 2020 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $200 → $120 | $11.81 | +916.09% | 1 | Mar 5, 2020 | |
| ITRM Iterum Therapeutics | Initiates: Buy | n/a | $1.22 | - | 1 | Jun 19, 2018 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | n/a | $491.57 | - | 1 | Jun 23, 2017 | |
| RGLS Regulus Therapeutics | Downgrades: Hold | n/a | $1.65 | - | 1 | Jan 30, 2017 |
Moderna
Dec 9, 2020
Downgrades: Hold
Price Target: n/a
Current: $121.14
Upside: -
Vir Biotechnology
Aug 20, 2020
Initiates: Buy
Price Target: n/a
Current: $10.03
Upside: -
CRISPR Therapeutics AG
Jul 28, 2020
Maintains: Buy
Price Target: n/a
Current: $54.56
Upside: -
Vaxcyte
Jul 7, 2020
Initiates: Buy
Price Target: n/a
Current: $81.63
Upside: -
Pliant Therapeutics
Jun 29, 2020
Initiates: Buy
Price Target: n/a
Current: $12.36
Upside: -
Alnylam Pharmaceuticals
May 6, 2020
Maintains: Buy
Price Target: n/a
Current: $237.83
Upside: -
Cidara Therapeutics
Mar 5, 2020
Maintains: Buy
Price Target: $200 → $120
Current: $11.81
Upside: +916.09%
Iterum Therapeutics
Jun 19, 2018
Initiates: Buy
Price Target: n/a
Current: $1.22
Upside: -
Vertex Pharmaceuticals
Jun 23, 2017
Upgrades: Buy
Price Target: n/a
Current: $491.57
Upside: -
Regulus Therapeutics
Jan 30, 2017
Downgrades: Hold
Price Target: n/a
Current: $1.65
Upside: -